Healthleap raises $38M to sell hospitals record screening with outcome-based pricing
Sequoia and First Round co-led an $8 million seed and Hummingbird led a $30 million Series A, TechCrunch reported. Healthleap's software flags inpatients for review; the company says it does not diagnose.

- Amount
- $38M
- Type
- Series A
- Company
- Healthleap
- Led by
- Hummingbird Ventures, Sequoia Capital, First Round Capital
- Sector
- Health AI
- Announced
- Oct. 7, 2026
Healthleap's software reads every adult inpatient's chart overnight and tells the care team by morning which patients might warrant a second look. The company has raised $38 million to extend that screening to more conditions, according to its announcement and a TechCrunch report published Oct. 7.
TechCrunch reported that Sequoia Capital and First Round Capital co-led an $8 million seed round, and Hummingbird Ventures led a $30 million Series A. The company did not disclose its valuation.
Why it matters: Healthleap pitches its screening to hospitals in financial terms as well as clinical ones. TechCrunch reported that its three-year contracts are priced by licensed bed count with an outcome-based component, and the company says hospitals can be paid roughly $11,000 when a patient is diagnosed with severe malnutrition, the first condition it targeted.
How it works
Healthleap hooks into a hospital's EHR system and applies language models to clinicians' written notes, extracting mentions of swallowing problems or recent weight loss, TechCrunch reported. Those signals feed risk models alongside structured data like lab results and vital signs, and the scores appear inside the tools clinicians already use.
The company told TechCrunch that its software does not diagnose patients and only highlights items for further review.
Healthleap said it plans to move beyond malnutrition to pressure ulcers, congestive heart failure and hospital-acquired infections. Separate programs for heart failure readmission risk, aspiration pneumonia and pressure ulcers are still undergoing clinical validation, Josiah Meyer, the co-founder and chief executive, told TechCrunch.
The two sources gave different customer counts. Healthleap's announcement says it screens every adult inpatient daily at over 20 hospitals, naming Penn Medicine, Houston Methodist, Cedars-Sinai and Emory Healthcare. Meyer told TechCrunch the platform is deployed at more than 50 hospitals, up from three partners a year earlier, and listed Intermountain among its customers.
Meyer also told TechCrunch that Healthleap contractually commits to returns worth several times the contract price, as measured by financial results the hospital's own finance team validates. He said revenue grew more than tenfold over the past year but did not give figures.
"Every week, millions of patients leave hospitals with unresolved health conditions," Meyer said in the company's announcement.
The backstory
Meyer and his co-founder and sibling, Jemima Meyer, started the company in 2022 in South Africa, TechCrunch reported. Healthleap began as a clinical nutrition tool that Jemima Meyer, a clinician, built for dietitians, then broadened into a general-purpose platform.
Alfred Lin, a partner at Sequoia Capital, said in the announcement that Healthleap "is focused on finding patients who are being missed and getting them the care they need."
Healthleap said it will spend the money on more conditions and on hiring across product, engineering, sales and customer success. Meyer told TechCrunch the company aims eventually to address over 40 major conditions and to reach patients in outpatient and home settings.



